128 related articles for article (PubMed ID: 37522251)
1. A Prognostic Model To Predict Survival After Recurrence Among Patients With Recurrent Hepatocellular Carcinoma.
Moazzam Z; Alaimo L; Endo Y; Lima HA; Woldesenbet S; Rueda BO; Yang J; Ratti F; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Guglielmi A; Hugh T; Aldrighetti L; Shen F; Endo I; Pawlik TM
Ann Surg; 2024 Mar; 279(3):471-478. PubMed ID: 37522251
[TBL] [Abstract][Full Text] [Related]
2. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
[TBL] [Abstract][Full Text] [Related]
3. Clinical and morpho-molecular classifiers for prediction of hepatocellular carcinoma prognosis and recurrence after surgical resection.
Zhang X; Bai Y; Xu L; Zhang B; Feng S; Xu L; Zhang H; Xu L; Yang P; Niu T; Zheng S; Liu J
Hepatol Int; 2019 Nov; 13(6):715-725. PubMed ID: 31531761
[TBL] [Abstract][Full Text] [Related]
4. A Novel Online Calculator to Predict Risk of Microvascular Invasion in the Preoperative Setting for Hepatocellular Carcinoma Patients Undergoing Curative-Intent Surgery.
Endo Y; Alaimo L; Lima HA; Moazzam Z; Ratti F; Marques HP; Soubrane O; Lam V; Kitago M; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2023 Feb; 30(2):725-733. PubMed ID: 36103014
[TBL] [Abstract][Full Text] [Related]
5. Early extrahepatic recurrence as a pivotal factor for survival after hepatocellular carcinoma resection: A 15-year observational study.
Yoon JH; Choi SK; Cho SB; Kim HJ; Ko YS; Jun CH
World J Gastroenterol; 2022 Sep; 28(36):5351-5363. PubMed ID: 36185633
[TBL] [Abstract][Full Text] [Related]
6. Estimating postsurgical outcomes of patients with a single hepatocellular carcinoma using gadoxetic acid-enhanced MRI: risk scoring system development and validation.
Park SH; Kim B; Kim S; Park S; Park YH; Shin SK; Sung PS; Choi JI
Eur Radiol; 2023 May; 33(5):3566-3579. PubMed ID: 36933020
[TBL] [Abstract][Full Text] [Related]
7. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
8. Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival.
Yuan Z; Wang Y; Hu C; Gao W; Zheng J; Li W
Technol Cancer Res Treat; 2018 Jan; 17():1533033818801362. PubMed ID: 30244651
[TBL] [Abstract][Full Text] [Related]
9. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
[TBL] [Abstract][Full Text] [Related]
10. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.
Mazzaferro V; Sposito C; Zhou J; Pinna AD; De Carlis L; Fan J; Cescon M; Di Sandro S; Yi-Feng H; Lauterio A; Bongini M; Cucchetti A
Gastroenterology; 2018 Jan; 154(1):128-139. PubMed ID: 28989060
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features and risk factors for extrahepatic recurrences of hepatocellular carcinoma after curative resection.
Ochiai T; Ikoma H; Okamoto K; Kokuba Y; Sonoyama T; Otsuji E
World J Surg; 2012 Jan; 36(1):136-43. PubMed ID: 22051887
[TBL] [Abstract][Full Text] [Related]
12. Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?
Hsieh CB; Chen TW; Chu CM; Chu HC; Yu CP; Chung KP
World J Gastroenterol; 2010 Jun; 16(24):3049-55. PubMed ID: 20572309
[TBL] [Abstract][Full Text] [Related]
13. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
[TBL] [Abstract][Full Text] [Related]
14. A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.
Umeda Y; Matsuda H; Sadamori H; Matsukawa H; Yagi T; Fujiwara T
World J Surg; 2011 Jan; 35(1):170-7. PubMed ID: 20922387
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
Kuo MJ; Mo LR; Chen CL
BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium.
Tran BV; Moris D; Markovic D; Zaribafzadeh H; Henao R; Lai Q; Florman SS; Tabrizian P; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Hoteit M; Levine MH; Cillo U; Vitale A; Verna EC; Halazun KJ; Tevar AD; Humar A; Chapman WC; Vachharajani N; Aucejo F; Lerut J; Ciccarelli O; Nguyen MH; Melcher ML; Viveiros A; Schaefer B; Hoppe-Lotichius M; Mittler J; Nydam TL; Markmann JF; Rossi M; Mobley C; Ghobrial M; Langnas AN; Carney CA; Berumen J; Schnickel GT; Sudan DL; Hong JC; Rana A; Jones CM; Fishbein TM; Busuttil RW; Barbas AS; Agopian VG
Liver Transpl; 2023 Jul; 29(7):683-697. PubMed ID: 37029083
[TBL] [Abstract][Full Text] [Related]
17. Predicting Mortality in Patients Developing Recurrent Hepatocellular Carcinoma After Liver Transplantation: Impact of Treatment Modality and Recurrence Characteristics.
Bodzin AS; Lunsford KE; Markovic D; Harlander-Locke MP; Busuttil RW; Agopian VG
Ann Surg; 2017 Jul; 266(1):118-125. PubMed ID: 27433914
[TBL] [Abstract][Full Text] [Related]
18. Serum α-Fetoprotein Levels at Time of Recurrence Predict Post-Recurrence Outcomes Following Resection of Hepatocellular Carcinoma.
Tsilimigras DI; Moris D; Hyer JM; Bagante F; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2021 Nov; 28(12):7673-7683. PubMed ID: 33907924
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis.
Vidal RIO; Vidal EIO; Pereira BB; Assane CC; Ribeiro A; do Nascimento EM; Romeiro FG; Ribeiro Filho J
Biomed Res Int; 2020; 2020():1487593. PubMed ID: 33134370
[TBL] [Abstract][Full Text] [Related]
20. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
